6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol,2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-, (2R,3R,3aS,9aR)- cas no:31698-14-3
Synonyms: 2,2'-O-Cyclocytidine;Cyclocytidine;O2,2'-Cyclocytidine;O2:2'-Anhydro-1-b-D-arabinosylcytosine;6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol,2,3,3a,9a-tetrahydro-3-hydroxy-6-imino- (6CI);6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol,2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-, stereoisomer (8CI);2,2'-Anhydro(1-b-D-arabinofuranosyl)cytosine;2,2'-Anhydroarabinosylcytosine;2,2'-Anhydrocytidine;2,2'-Cyclocytidine;
Name6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol,2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-, (2R,3R,3aS,9aR)-
CAS31698-14-3
Synonyms2,2'-O-Cyclocytidine;Cyclocytidine;O2,2'-Cyclocytidine;O2:2'-Anhydro-1-b-D-arabinosylcytosine;6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol,2,3,3a,9a-tetrahydro-3-hydroxy-6-imino- (6CI);6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol,2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-, stereoisomer (8CI);2,2'-Anhydro(1-b-D-arabinofuranosyl)cytosine;2,2'-Anhydroarabinosylcytosine;2,2'-Anhydrocytidine;2,2'-Cyclocytidine;
Molecular FormulaC9H11N3O4
Molecular Weight225.2
Safety
Moderately toxic by ingestion, intravenous, and intraperitoneal routes. Mildly toxic by subcutaneous route. When heated to decomposition it emits toxic fumes of NOx.
Organism |
Test Type |
Route |
Reported Dose (Normalized Dose) |
Effect |
Source |
mouse |
LD50 |
intraperitoneal |
1600mg/kg (1600mg/kg) |
PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE)
BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY)
LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION |
Eksperimental'naya i Klinicheskaya Farmakoterapiya. Vol. 9, Pg. 31, 1980. |
mouse |
LD50 |
intravenous |
800mg/kg (800mg/kg) |
|
Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 7, Pg. 108, 1976. |
mouse |
LD50 |
oral |
3400mg/kg (3400mg/kg) |
PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE)
BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY)
LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION |
Eksperimental'naya i Klinicheskaya Farmakoterapiya. Vol. 9, Pg. 31, 1980. |
mouse |
LD50 |
subcutaneous |
4050mg/kg (4050mg/kg) |
|
Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 7, Pg. 108, 1976. |
rat |
LD50 |
intraperitoneal |
1700mg/kg (1700mg/kg) |
PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE)
BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY)
LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION |
Eksperimental'naya i Klinicheskaya Farmakoterapiya. Vol. 9, Pg. 31, 1980. |
rat |
LD50 |
intravenous |
820mg/kg (820mg/kg) |
|
Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 7, Pg. 108, 1976. |
rat |
LD50 |
oral |
> 7gm/kg (7000mg/kg) |
|
Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 7, Pg. 108, 1976. |